1. Waelgaard L, Thorgersen EB, Line PD, et. al. Microdialysis monitoring of liver grafts by metabolic parameters, cytokine production, and complement activation. Transplantation 2008; 86(8): 1096–1103.
2. Cibiček N, Živna H, Čermakova E, et. al. Sledování krevního průtoku v žaludku pomocí mikrodialýzy na potkaním modelu ischemie-reperfuze Klin Biochem Metab 2010; 18(39): 36–240.
3. Rostami E, Bellander BM. Monitoring of glucose in brain, adipose tissue, and peripheral blood in patients with traumatic brain injury: a microdialysis study. J Diabetes Sci Technol 2011; 5(3): 596–604.
4. Liu X, Kruger PS, Roberts MS. How to Measure Pharmacokinetics in Critically Ill Patients? Curr Pharm Biotechnol 2011; May 10 [Epub ahed of print].
5. Douglas A, Altukroni M, Udy AA, et. al. The pharmacokinetics of cefazolin in patients undergoing elective & semi–elective abdominal aortic aneurysm open repair surgery. BMC Anesthesiol 2011; 11: 5.
6. Simon F, Karlander, LE, et. al. Continous assessment of concentrations of cytokines in experimentak injurie sof the extremity. Exp Med 2009; 2(4): 354–362.
7. Roberts JA, Roberts MS, Semark A, et al. Antibiotic dosing in the ‘at risk’ critically ill patient: Linking pathophysiology with pharmacokinetics/pharmacodynamics in sepsis and trauma patients. BMC Anesthesiol 2011; 11: 3.
8. Jansson L. et al. Postoperative on-line monitoring with intraperitoneal microdialysis is a sensitive clinical method for measuring increased anaerobic metabolism that correlates to the cytokine response. Scand 2004; 39(5): 434–439.
9. Widegren U, Hickner RC, Jorfeldt L, Henriksson J. Muscle blood flow response to mental stress and adrenaline infusion in man: microdialysis ethanol technique compared to (133)Xe clearance and venous occlusion plethysmography. Clin Physiol Funct Imaging 2010; 30(2): 152–161.
10. Farnebo S, Zettersten EK, Samuelsson A, Tesselaar E, Sjöberg F. Assessment of blood flow changes in human skin by microdialysis urea clearance. Microcirculation 2011; 18(3): 198–204.
11. Farnebo S, Samuelsson A, Henriksson J, et. al. Urea clearance: a new method to register local changes in blood flow in rat skeletal muscle based on microdialysis. Clin 2010; 30(1): 57–63.
12. Bruno L, Sébastien G, Patricia F, et al. Relation between muscle Na+K+ ATPase activity and raised lactate concentration in septic shock:a prospective study. The Lancet 2005; 365: 9462.
13. Ohashi S, et al. Utility of microdialysis to detect the lactate/pyruvateratio in subcutaneous tissue for the reliable monitoring of hemorrhagic shock. Res 2009; 45(6): 269–278.
14. Samuelsson A, Steinvall I, Sjoberg F. Microdialysis shows metabolit effects in skin during fluid resuscitation in burn-injured patiens. Crit Care 2006; 10(6): R172.
15. Farnebo S, Zettersten A. Assessment of blood flow changes in human skin by microdialysis urea clearance. Microcirculation 2011; 18(3): 198–204.
16. Levy B, Desebbe O, Montemont C, et al. Increased aerobic glycolysis through beta2 stimulation is a common mechanism involved in lactate formation during shock states. Shock 2008; 30(4): 417–421.
17. Krejci V, Hiltebrand L, et al. Decreasing gut wall glucose as an early marker of impaired intestinal perfusion Critical Care Medicine 2006; 34: 2406–2414.
18. Allam Cl, Xu M, Mendendorp A. Determination of Renal Hypothermic Temperature Adequacy for Renoprotection During Ischemia Using Renal Interstitial Glycerol Concentrations in a Porcine Model Urology 2011; 77(2): 508.e1–4.
19. SolligĆrd E, Jue IS, Bakkelund K, et al. Gut luminal microdialysis of glycerol as a marker of intestinal ischemic injury and recovery. Department of Anesthesiology and Intensive Care 2005; 33(10): 2278–2285.
20. Petriczko E, Horodnicka-Jozwa A, Grabowska-Wnuk W, et al. Interstitial measurements of glucose, glycerol and lactate in adolescents with decompensated type 1 diabetes. Neuro Endocrinol Lett 2010; 31(4): 559–567.
21. Trzeciak S, McCoy JV, Philip Dellinger R, et al. Early increases in microcirculatory perfusion during protocol–directed resuscitation are associated with reduced multi–organ failure at 24 h in patients with sepsis. Intensive Care Med 2008; 34(12): 2210–2217.
22. Adams RC, Lundy JS. Anesthesia in cases of poor surgical risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet 1942; 74: 1011–1019.
23. Weiskopf RB, Viele MK, Feiner J, Kelley, et al. Human cardiovascular and metabolic response to acute, severe isovolemic anemia. JAMA 1998; 279: 217–221.
24. Lieberman JA, Weiskopf RB, Kelley SD, et al. Critical oxygen delivery in conscious humans is less than 7.3 mL O2 × kg (-1) × min (-1). Anesthesiology 2000; 92: 407–413.
25. Brimacombe J, Skippen P, Talbutt P. Acute anemia to a hemoglobin of 14 g/lwith survival. Anaesth Intensive Care 1991; 19: 581–583.
26. Hill SR, Carless PA, Henry DA, et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev2002: CD002042.
27. Madjdpour C, Spahn DR, Weiskopf RB. Anemia and perioperative red blood cell transfusion:a matter of tolerance. Crit Care Med 2006; 34: S102–108.
28. Walsh TS, Saleh EE. Anaemia during critical illness. Br J Anaesth 2006; 97: 278–291.
29. Hebert PC, Wells G, Blajchman MA, et. al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409–417.
30. Koch CG, Li L, Duncan AI, Mihaljevic T, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg 2006; 81: 1650–1657.
31. Vincent JL, Baron J-F, Reinhart K, et al. Anemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499–1507.
32. Stainsby D, MacLennan S, Thomas, D et al. Guidelines on the management of massive blood loss. Br J Haematol 2006; 135(5): 634–641.
33. Sehgal LR, Zebala LP, Takagi I, et al. Evaluation of oxygen extraction ratio as a physiologic transfusion trigger in coronary artery bypass graft surgery patients. Transfusion 2001; 41: 591–595.
34. Vázquez BY, Hghtower CM, Martini J. Vasoactive hemoglobin solution improves survival in hemodilution followed by hemorrhagic shock. Crit Care Med 2011; 39(6): 1461–1466.
35. Boldt J, Ince C. The impact of fluid therapy on microcirculation and tissue oxygenation in hypovolemic patients: a review. Care Med 2010; 36(8): 1299–1308.
36. Samir M Fakhry, Fata P. How low is too low? Cardiac risks with anemia. Crit Care 2004; 8(Suppl 2): S11–14.
37. Dubin A, Pozo MO, Ferrara G. Systemic and microcirculatory responses to progressive hemorrhage. Intensive Care Med 2009; 35(3): 556–564.